Colorado MEDtech, CMED Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Colorado MEDtech, CMED

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: DALTS who wrote (135)	10/9/1998 3:49:00 PM
From: Edward Larkin	Read Replies (1) of 288

This company has one seasonally impacted quarter a year, and it is the September quarter. The reason is due to the fact that about 1/2 of their revenues come from contract research and development for major companies. Why this effects them is simple, since most R&D projects are billed to the client on a billable hour basis, the company has less than normal hours billed in the July and August months due to most employees taking the majority of their vacation time annually during these months. The outlook remains great, ADVEST recently initiated coverage with a 65 cent estimate for 2000, and followed the concensus of 50 cents for fiscal 99. We are trading at about 12.5X the current fiscal year estimate with a 40% growth rate. If they add an an acquisition this year, the numbers will increase since none of the analysts have an acquisition built into their models.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next